Navigation Links
NDI Announces New Healthcare Venture Fund
Date:1/31/2011

CLEVELAND, Jan. 31, 2011 /PRNewswire/ -- NDI has launched the NDI Healthcare Fund, a new commercialization fund focused on developing innovative neurodevice technologies.  The Fund recently raised $8 million from equity investments and a grant from the State of Ohio.

(Logo: http://photos.prnewswire.com/prnh/20110131/DC38962LOGO)

"The NDI Healthcare Fund will invest in both seed-stage neurodevice companies and technologies," said Geoff Thrope, NDI's CEO, founder and president. "We are looking for product opportunities in large markets where there is at least one validated product, but where critical clinical needs still exist."

NDI is a leader in commercializing innovative neurodevice technologies to address significant unmet health conditions, improve patients' lives, and provide significant returns to investors.  Over the past decade, NDI's team of neurodevice entrepreneurs, scientists and professionals has developed products to restore lost neurological function, prevent damage, and reduce the effects of disease and injury.  

In April 2008, NDI sold its MEDSTIM urinary incontinence system to Medtronic for $42 million.  

Since then, the company has raised an additional $15 million in private equity and another $7 million in grants and loans from the State of Ohio's Third Frontier Program and the NIH.  

NDI invests these funds in its unique platform of technologies, pipeline of commercialization opportunities, and portfolio companies, including Checkpoint Surgical and SPR™ Therapeutics.  

Checkpoint Surgical provides physicians with medical devices to locate, evaluate and preserve nerves and muscles in surgical procedures for better patient outcomes. SPR™ Therapeutics is developing patented nerve stimulation products for treating chronic and severe pain.

NDI maintains core capabilities under one roof -- including clinical and regulatory affairs, engineering and product development, operations and research -- to assess, develop and generate neurodevice products and companies. NDI is headquartered in Cleveland, Ohio, one of the world's leading centers of neurodevice research and innovation.

For more information on NDI, please contact Jackie Greiner at (216) 378-9106, ext. 117 or email at jgreiner@ndimedical.com.


'/>"/>
SOURCE NDI
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DNA Direct Announces New Health Plan Clients Managing Molecular Diagnostic and Genetic Tests
2. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
3. Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator
4. Endologix Announces Favorable Clinical Results for Nellix Technology
5. Bayer Animal Health Announces the Launch of Advantage® II and K9 Advantix® II
6. Qforma, Leading Provider of Healthcare Analytics, Announces Three New Appointments
7. Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
8. Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
9. Physiotherapy Associates Announces New Clinic in Castle Rock, CO
10. Awarepoint Announces RTLS in Healthcare Leadership with 2010 Results
11. Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... 2017 Viverae ® , a leader in ... of IBM ® Watson Campaign Automation, implementing behavioral ... for a personalized experience. Through digital engagement, the platform ... in real time. The enhanced experience drives engagement by ... wherever they are in their journey to health. ...
(Date:4/18/2017)... April 18, 2017  Astute Medical, Inc., developer of ... to be presented at the 2017 National Kidney Foundation ... and continues through April 22. Physicians will present data ... to assess risk for acute kidney injury (AKI) during ... (ADHF). Elevated levels of TIMP-2 and ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
(Date:4/24/2017)... ... ... Michael Vick announced his retirement earlier this year from the NFL after ... pick in the 2001 NFL Draft, to the Atlanta Falcons, made four Pro Bowl ... rushing yards by a quarterback (6,109) and the most rushing yards by a quarterback ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director ... Communication of Education Research Award. The award honors scholars exemplary in their capacity ... a scholar who has demonstrated the capacity to deepen the public’s understanding and ...
(Date:4/24/2017)... ... 24, 2017 , ... Sean Fay is the undisputed king of the infomercial. ... and the George Foreman Grill (which sold more than 100 million units worldwide), he ... years. , Now, due to changes in the broadcast media landscape, the once ever-present ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... that they are seeking public support to bring their novel lifesaving device for ... wearable device packed with medical-grade sensors, specially designed to read a child’s vital ...
Breaking Medicine News(10 mins):